Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by the targeted destruction of insulin-producing pancreatic β-cells, resulting in insulin deficiency and the requirement for lifelong exogenous insulin therapy to regulate blood glucose levels [1]. Here, INS is linked to type 1 diabetes mellitus.